- Report
- May 2026
- 150 Pages
Global
From €2486EUR$2,699USD£2,096GBP
- Report
- May 2026
- 150 Pages
Global
From €2486EUR$2,699USD£2,096GBP
- Report
- May 2026
- 150 Pages
Global
From €2486EUR$2,699USD£2,096GBP
- Report
- April 2026
- 137 Pages
Global
From €3683EUR$3,999USD£3,105GBP
- Report
- August 2026
- 150 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- July 2026
- 112 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- April 2026
- 180 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- April 2026
- 180 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- January 2026
- 120 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- August 2026
- 120 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- August 2026
- 92 Pages
Global
From €16574EUR$17,995USD£13,974GBP
- Report
- April 2026
- 91 Pages
Global
From €3500EUR$4,071USD£3,054GBP
- Report
- April 2026
- 99 Pages
Global
From €3500EUR$4,071USD£3,054GBP
- Report
- March 2026
- 209 Pages
Global
From €4559EUR$4,950USD£3,844GBP
- Report
- March 2026
- 107 Pages
Asia Pacific
From €3638EUR$3,950USD£3,067GBP
- Report
- March 2026
- 80 Pages
Middle East, Africa
From €3178EUR$3,450USD£2,679GBP
- Report
- March 2026
- 88 Pages
North America
From €3178EUR$3,450USD£2,679GBP
- Report
- June 2022
- 135 Pages
Global
From €2072EUR$2,250USD£1,747GBP
- Report
- May 2025
- 150 Pages
Global
From €5480EUR$5,950USD£4,621GBP
- Report
- July 2025
Global
From €4513EUR$4,900USD£3,805GBP

Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms.
Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders.
The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more